Clinical Chemistry Controls
American Research Products Inc CREATININE CR COLORIMETRIC KIT
5000265024 CREATININE CR COLORIMETRIC KIT
American Research Products Inc ANGIOTENSIN I CONVERTING ENZYM
5000265161 ANGIOTENSIN I CONVERTING ENZYM
American Research Products Inc CHOLESTEROL KIT FLUOROMETRIC B
5000265277 CHOLESTEROL KIT FLUOROMETRIC B
American Research Products Inc TOTAL BILE ACID TBA COLORIMETR
5000265369 TOTAL BILE ACID TBA COLORIMETR
Roche Diagnostics Control OD Level 3 Bio 6 x 1mL
This product is intended for quality control by monitoring accuracy and precision of the quantitative tests on the Cedex Bio and Cedex Bio HT Analyzers. Control OD Level 3 Bio provides an optical densitiy at 583 nm in the upper part of the measuring range of the OD test.Use this control as described in the instructions of the respective test.
Inorganic Ventures Deionized Water Blank
Inorganic Ventures' Deionized Water Blank is a 500mL reference material set in a water matrix for stability. This ICP blank is Traceable to NIST and manufactured in accordance with our stringent Quality Assurance guidelines. See Certificate of Analysis for expiration.
ATTENTION: Inorganic Ventures is no longer supplying paper copies of Certificate of Analyses(CoA) and Safety Data Sheets (SDS). Please use this link to download your copies: https://www.inorganicventures.com/coa-sds-search
HANNAS PHARMACEUTICAL SUPPLY CO INC ACCU-CHEKGUIDETESTSTRIPS -50PK
NC3345809 ACCU-CHEKGUIDETESTSTRIPS -50PK
Cayman Chemical FerrItIn Heavy ChaInhumn200ug
Source: Recombinant human ferritin heavy chain expressed in E. coli • Amino acids: 1-183 (full length) • MW: 21.2 kDa
AdipoGen Digoxin
Chemical. CAS 20830-75-5. Formula C41H64O14. MW 780.94. Synthetic. Cardiac glycoside from the leaves of Digitalis lanata. It is used to treat cardiac arrhythmias. It is often used as a model substrate of P-glycoprotein Pgp 0.01-10µM and an inhibitor of Na/K-ATPase. Inhibits membrane-bound alpha-subunits of the Na/K ATPase pump in myocytes. The primary mechanism of action involves inhibition of the Na/K ATPase, mainly in the myocardium. This inhibition causes an increase in intracellular sodium levels, resulting in a reversal of the action of the sodium-calcium exchanger, which causes an increase in the intracellular calcium concentration. This leads to a decrease in heart rate and increased storage of calcium in the sarcoplasmic reticulum, causing a corresponding increase in the release of calcium during each action potential.